Viewing Study NCT06109233

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-03-05 @ 5:46 AM
Study NCT ID: NCT06109233
Status: RECRUITING
Last Update Posted: 2024-07-05
First Post: 2023-10-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment
Sponsor: FengYan Jin
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Minimal Residual Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None MRD-tailored therapy View
None MRD status View
None MRD-negative rates View
None Survival View